Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Sep 30:2025:8541641.
doi: 10.1155/crom/8541641. eCollection 2025.

A Rare Cervical Manifestation of Acute Myeloid Leukemia: Granulocytic Sarcoma Simulating as a Gynecologic Tumor

Affiliations
Case Reports

A Rare Cervical Manifestation of Acute Myeloid Leukemia: Granulocytic Sarcoma Simulating as a Gynecologic Tumor

Figen Efe Çamili et al. Case Rep Oncol Med. .

Abstract

Granulocytic sarcoma (GS) is an extramedullary accumulation of proliferating myeloblasts, most commonly seen in patients with acute myeloid leukemia (AML) but rarely associated with chronic myeloid leukemia, myelodysplastic syndromes, or myeloproliferative neoplasms. The skin is the most frequent site of extramedullary relapse, followed by the mediastinum, gingiva, ear, lymph nodes, central nervous system, and testis. We report a case of a 38-year-old female who presented to our clinic with abnormal vaginal bleeding. She had a history of bone marrow transplantation 5 years ago for AML. Based on clinical suspicion, a cervical biopsy was performed, which confirmed the diagnosis of GS. Although GS involving the female reproductive tract is rare, it should be considered in the differential diagnosis of abnormal gynecologic symptoms in patients with a history of AML.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Sheets of medium-sized immature cells with clear cytoplasm and abundant mitotic figures (H&E ×400).
Figure 2
Figure 2
Strong cytoplasmic immunoreactivity for myeloperoxidase (MPO ×400).

References

    1. Shallis R. M., Gale R. P., Lazarus H. M., et al. Myeloid Sarcoma, Chloroma, or Extramedullary Acute Myeloid Leukemia Tumor: A Tale of Misnomers, Controversy and the Unresolved. Blood Reviews . 2021;47 doi: 10.1016/j.blre.2020.100773.100773 - DOI - PubMed
    1. Khoury J. D., Solary E., Abla O., et al. The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia . 2022;36(7):1703–1719. doi: 10.1038/s41375-022-01613-1. - DOI - PMC - PubMed
    1. Disel U., Yavuz S., Paydas S., Sahin B., Zeren H. Extramedullary Relapse in the Pleura in Acute Promyelocytic Leukemia. Leukemia & Lymphoma . 2003;44(1):189–191. doi: 10.1080/1042819031000057270. - DOI - PubMed
    1. Goyal G., Bartley A. C., Patnaik M. M., Litzow M. R., Al-Kali A., Go R. S. Clinical Features and Outcomes of Extramedullary Myeloid Sarcoma in the United States: Analysis Using a National Data Set. Cancer Journal . 2017;7(8):p. e592. doi: 10.1038/bcj.2017.79. - DOI - PMC - PubMed
    1. Au W. Y., Chan G. C. F., Chim C. S., et al. Unusual Sites of Involvement by Hematologic Malignancies. Journal of Clinical Oncology . 2001;19(19):3993–3995. doi: 10.1200/JCO.2001.19.19.3993. - DOI - PubMed

Publication types

LinkOut - more resources